Regeneron And Sanofi Have A Near-Term FDA Catalyst By: Benzinga via Benzinga May 22, 2017 at 14:08 PM EDT At the end of April, biotech company Regeneron Pharmaceuticals Inc (NASDAQ: REGN) announced that the FDA had accepted the resubmission ... Read More >> Related Stocks: AbbVie Regeneron Pharmaceuticals Sanofi-Aventis S.A. ADR